These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27021151)

  • 1. Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in mice.
    Wendelboe MH; Thomsen JS; Henriksen K; Vegger JB; Brüel A
    Bone; 2016 Jun; 87():27-36. PubMed ID: 27021151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats.
    Vegger JB; Nielsen ES; Brüel A; Thomsen JS
    Bone; 2014 Sep; 66():287-95. PubMed ID: 24970039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice.
    Sørensen TG; Brent MB; Thomsen JS; Brüel A
    Bone; 2020 Feb; 131():115183. PubMed ID: 31794846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
    Sheng ZF; Xu K; Ma YL; Liu JH; Dai RC; Zhang YH; Jiang YB; Liao EY
    Osteoporos Int; 2009 Jan; 20(1):151-9. PubMed ID: 18496637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic but no local effects of combined zoledronate and parathyroid hormone treatment in experimental autoimmune arthritis.
    Keller KK; Thomsen JS; Stengaard-Pedersen K; Hauge EM
    PLoS One; 2014; 9(3):e92359. PubMed ID: 24637846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys.
    Binkley N; Kimmel D; Bruner J; Haffa A; Davidowitz B; Meng C; Schaffer V; Green J
    J Bone Miner Res; 1998 Nov; 13(11):1775-82. PubMed ID: 9797488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy.
    Li GW; Chang SX; Fan JZ; Tian YN; Xu Z; He YM
    Bone; 2013 Feb; 52(2):668-75. PubMed ID: 23142803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.
    Ardawi MM; Badawoud MH; Hassan SM; Rouzi AA; Ardawi JMS; AlNosani NM; Qari MH; Mousa SA
    Bone; 2016 Feb; 83():127-140. PubMed ID: 26549245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of Calcitriol Causes Increased Lactational Bone Loss and Lower Milk Calcium but Does Not Impair Post-lactation Bone Recovery in Cyp27b1 Null Mice.
    Gillies BR; Ryan BA; Tonkin BA; Poulton IJ; Ma Y; Kirby BJ; St-Arnaud R; Sims NA; Kovacs CS
    J Bone Miner Res; 2018 Jan; 33(1):16-26. PubMed ID: 28686309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.
    Perosky JE; Khoury BM; Jenks TN; Ward FS; Cortright K; Meyer B; Barton DK; Sinder BP; Marini JC; Caird MS; Kozloff KM
    Bone; 2016 Dec; 93():79-85. PubMed ID: 27641475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
    Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
    Bauss F; Lalla S; Endele R; Hothorn LA
    J Rheumatol; 2002 Oct; 29(10):2200-8. PubMed ID: 12375334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal changes during lactation and after weaning in osteocyte-specific sclerostin overexpressed mice.
    Lee SJ; Song SY; Rhee Y
    J Bone Miner Metab; 2020 Mar; 38(2):172-178. PubMed ID: 31501981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does locally delivered Zoledronate influence peri-implant bone formation? - Spatio-temporal monitoring of bone remodeling in vivo.
    Kettenberger U; Ston J; Thein E; Procter P; Pioletti DP
    Biomaterials; 2014 Dec; 35(37):9995-10006. PubMed ID: 25241159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.